Delving deeper into MALT lymphoma biology

被引:46
作者
Bertoni, F
Zucca, E
机构
[1] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[2] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland
关键词
D O I
10.1172/JCI27476
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mucosa-associated lymphoid tissue (MALT) lymphomas can arise in a variety of extranodal sites. Interestingly, at least 3 different, apparently site-specific, chromosomal translocations, all affecting the NF-kappa B pathway, have been implicated in the development and progression of MALT lymphoma. The most common is the translocation t(11;l8)(q21;q21), which results in a fusion of the cIAP2 region on chromosome 11q21 with the MALT1 gene on chromosome 18q21 and is present in more than one-third of cases. The frequency of this translocation is site-related: common in the gastrointestinal tract and lung, rare in conjunctiva and orbit, and almost absent in salivary glands, thyroid, liver, and skin. In this issue of the JCI, Hu et al. add to our understanding of the molecular consequences of this translocation, showing that its fusion product, cIAP2-MALT1, may concomitantly contribute to lymphomagenesis both as a tumor suppressor gene and as an oncogene (see the related article beginning on page 174).
引用
收藏
页码:22 / 26
页数:5
相关论文
共 32 条
  • [1] State-of-the-art therapeutics: Marginal-zone lymphoma
    Bertoni, F
    Zucca, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6415 - 6420
  • [2] MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-κB activation
    Che, TJ
    You, Y
    Wang, DH
    Tanner, MJ
    Dixit, VM
    Lin, X
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) : 15870 - 15876
  • [3] Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
    Dave, SS
    Wright, G
    Tan, B
    Rosenwald, A
    Gascoyne, RD
    Chan, WC
    Fisher, RI
    Braziel, RM
    Rimsza, LM
    Grogan, TM
    Miller, TP
    LeBlanc, M
    Greiner, TC
    Weisenburger, DD
    Lynch, JC
    Vose, J
    Armitage, JO
    Smeland, EB
    Kvaloy, S
    Holte, H
    Delabie, J
    Connors, JM
    Lansdorp, PM
    Ouyang, Q
    Lister, TA
    Davies, AJ
    Norton, AJ
    Muller-Hermelink, HK
    Ott, G
    Campo, E
    Montserrat, E
    Wilson, WH
    Jaffe, ES
    Simon, R
    Yang, LM
    Powell, J
    Zhao, H
    Goldschmidt, N
    Chiorazzi, M
    Staudt, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (21) : 2159 - 2169
  • [5] The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
    Dierlamm, J
    Baens, M
    Wlodarska, I
    Stefanova-Ouzounova, M
    Hernandez, JM
    Hossfeld, DK
    De Wolf-Peeters, C
    Hagemeijer, A
    Van den Berghe, H
    Marynen, P
    [J]. BLOOD, 1999, 93 (11) : 3601 - 3609
  • [6] Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma
    Farinha, P
    Gascoyne, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) : 6370 - 6378
  • [7] GREINER A, 1994, LAB INVEST, V70, P572
  • [8] MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-κB-dependent proliferative advantage and resistance against FAS-induced cell death in B cells
    Ho, L
    Davis, RE
    Conne, B
    Chappuis, R
    Berczy, M
    Mhawech, P
    Staudt, LM
    Schwaller, J
    [J]. BLOOD, 2005, 105 (07) : 2891 - 2899
  • [9] cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas
    Hu, SM
    Du, MQ
    Park, SM
    Alcivar, A
    Qu, L
    Gupta, S
    Tang, J
    Baens, M
    Ye, HT
    Lee, TH
    Marynen, P
    Riley, JL
    Yang, XL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) : 174 - 181
  • [10] HUSSELL T, 1993, AM J PATHOL, V142, P285